Next, to study the relation between BMP antagonist expression and CXCL12 in humans, a publicly available the cancer genome atlas (TCGA) mRNA-expression data set from a colon adenocarcinoma cohort with survival data consisting of 155 patients was used. The gene discussed is CXCL12; the disease is colon adenocarcinoma.